Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on Roche Holding AG (RHHVF – Research ...

U.S. Public Interest Research Group, Service Employees International Union (SEIU) and others expressed concerns in a letter ...

Europe’s answer to the Magnificent Seven is leaving much to be desired after two of the Continent’s biggest companies, ASML Holding and LVMH Moet Hennessy, disappointed investors.

Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its ...

Cathie Wood, the CEO of Ark Invest, has several AI stocks in her investment management firm's actively managed ETFs. One of ...

Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...

Detailed price information for Jaguar Health Inc (JAGX-Q) from The Globe and Mail including charting and trades.

A smart beta exchange traded fund, the Hartford Multifactor Developed Markets (ex-US) ETF (RODM) debuted on 02/25/2015, and offers broad exposure to the Broad Developed World ETFs category of the ...

Pfizer Inc.’s Hympavzi won US approval to treat hemophilia, a potentially deadly genetic disorder that prevents blood from clotting properly.

Roche (RHHBY) has received FDA approval for its drug Itovebi in combination with two other drugs for the treatment of breast ...

PDUFA date, the U.S. FDA has approved Genentech Inc.’s first-line breast cancer treatment Itovebi (inavolisib). Itovebi is to be combined with Pfizer Inc.’s palbociclib (Ibrance) and fulvestrant for ...